Inhalational anesthetics in acute severe asthma

Current Drug Targets

Volumn 10, Issue 9, 2009, Pages 826-832

  Vaschetto, R ^a   Bellotti, E ^a   Turucz, E ^a   Gregoretti, C ^b   Della Corte, F ^a   Navalesi, P ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CTO HOSPITAL   (Italy)

Author keywords

Halothane; Inhalational anesthetics; Isoflurane; Near fatal asthma; Sevoflurane; Status asthmaticus

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; DESFLURANE; ENFLURANE; HALOTHANE; IPRATROPIUM BROMIDE; ISOFLURANE; ISOPRENALINE; KETAMINE; MAGNESIUM SULFATE; METHYLXANTHINE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; PROPOFOL; SALBUTAMOL; SEVOFLURANE; SUXAMETHONIUM; TERBUTALINE; THEOPHYLLINE;

ACUTE DISEASE; AMINOTRANSFERASE BLOOD LEVEL; ARTIFICIAL VENTILATION; ASTHMA; ASTHMATIC STATE; BRONCHODILATATION; BRONCHUS MUSCLE; CLINICAL FEATURE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG POTENTIATION; HEMODYNAMIC STRESS; HUMAN; HYPOTENSION; LOADING DRUG DOSE; NONHUMAN; OXYGEN SATURATION; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

ANESTHETICS, INHALATION; ASTHMA; HUMANS; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX;

EID: 70450176277     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945009789108747     Document Type: Review

References (60)

1. Tillie-Leblond I, Montani D, Crestani B, de Blic J, Humbert M, Tunon-de-Lara M, et al. Relation between inflammation and symptoms in asthma. Allergy 2009; DOI 10.1111/j.1398-9995.2009.01971.
2. Saetta M, Di SA, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138-143
3. Kenyon N, Albertson TE. Status asthmaticus. From the emergency department to the intensive care unit. Clin Rev Allergy Immunol 2001; 20: 271-292
4. McFadden ER, Jr., Warren EL. Observations on asthma mortality. Ann Intern Med 1997; 127: 142-147
5. Cressy DS, DeBoisblanc BP. Diagnosis and management of asthma: a summary of the National Asthma Education and Prevention Program guidelines. National Institutes of Health. J La State Med Soc 1998; 150: 611-617
6. Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J 1999; 13: 1198-1208
7. Levy BD, Kitch B, Fanta CH. Medical and ventilatory management of status asthmaticus. Intens Care Med 1998; 24: 105-117 (Pubitemid 28192090)
8. Corbridge TC, Hall JB. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med 1995; 151: 1296-1316
9. Alvarez GG, Schulzer M, Jung D, Fitzgerald JM. A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 2005; 12: 265-270 (Pubitemid 41387424)
10. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE. Severity assessment in asthma: An evolving concept. J Allergy Clin Immunol 2005; 116: 990-995 (Pubitemid 41571777)
11. McFadden ER, Jr., Elsanadi N, Dixon L, Takacs M, Deal EC, Boyd KK et al. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med 1995; 99: 651-661 (Pubitemid 26006447)
12. Karpel JP, Schacter EN, Fanta C, Levey D, Spiro P, Aldrich T et al. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest 1996; 110: 611-616 (Pubitemid 27009280)
13. Rodrigo C, Rodrigo G. Treatment of acute asthma. Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer. Chest 1994; 106: 1071-1076
14. Benatar SR. Fatal asthma. N Engl J Med 1986; 314: 423-429
15. Hughes R, Goldkorn A, Masoli M, Weatherall M, Burgess C, Beasley R. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet 2003; 361: 2114-2117 (Pubitemid 36782255)
16. Darioli R, Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984; 129: 385-387. (Pubitemid 14197254)
17. Beveridge RC, Grunfeld AF, Hodder RV, Verbeek PR. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. CMAJ 1996; 155: 25-37.
18. Conti G, Ferretti A, Tellan G, Rocco M, Lappa A. Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus. Intens Care Med 1993; 19: 305. (Pubitemid 23266006)
19. Clarkson K, Power CK, O'Connell F, Pathmakanthan S, Burke CM. A comparative evaluation of propofol and midazolam as sedative agents in fiberoptic bronchoscopy. Chest 1993; 104: 1029-1031 (Pubitemid 23306046)
20. Collier C, Kelly K. Propofol and convulsions - the evidence mounts. Anaesth Intens Care 1991; 19: 573-575
21. Gottardis M, Khunl-Brady KS, Koller W, Sigl G, Hackl JM. Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth 1989; 62: 393-396 (Pubitemid 19111719)
22. Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153: 1686-1690 (Pubitemid 26141357)
23. Levy ML, Thomas M, Small I, Pearce L, Pinnock H, Stephenson P. Summary of the 2008 BTS/SIGN British Guideline on the management of asthma. Prim Care Respir J 2009; 18 Suppl 1: S1-16.
24. Jagoda A, Shepherd SM, Spevitz A, Joseph MM. Refractory asthma, Part 1: Epidemiology, pathophysiology, pharmacologic interventions. Ann Emerg Med 1997; 29: 262-274 (Pubitemid 27053572)
25. Enright A. Bronchospastic disease and emergency surgery. Middle East J Anesthesiol 2004; 17: 927-938
26. Piat V, Dubois MC, Johanet S, Murat I. Induction and recovery characteristics and hemodynamic responses to sevoflurane and halothane in children. Anesth Analg 1994; 79: 840-844 (Pubitemid 24324658)
27. Kenna JG, Jones RM. The organ toxicity of inhaled anesthetics. Anesth Analg 1995; 81: S51-S66.
28. Shah MV, Hirshman CA. Mode of action of halothane on histamine-induced airway constriction in dogs with reactive airways. Anesthesiology 1986; 65: 170-174
29. DeNicola LK, Aboudan K. Resistant status asthmaticus in children. J Fla Med Assoc 1990; 77: 809-813
30. Baigel G. Volatile agents to avoid ventilating asthmatics. Anaesth Intens Care 2003; 31: 208-210 (Pubitemid 36503837)
31. Bayliff CD, Koch JP, Faclier G. The use of halothane in the treatment of status asthmaticus. Drug Intell Clin Pharm 1985; 19: 307-309 (Pubitemid 15052355)
32. Colaco CM, Crago RR, Weisbert A. Halothane for status asthmaticus in the Intens care unit - a case report. Can Anaesth Soc J 1978; 25: 329-330 (Pubitemid 9004926)
33. Echeverria M, Gelb AW, Wexler HR, Ahmad D, Kenefick P. Enflurane and halothane in status asthmaticus. Chest 1986; 89: 152-154
34. O'Rourke PP, Crone RK. Halothane in status asthmaticus. Crit Care Med 1982; 10: 341-343
35. Restrepo RD, Pettignano R, DeMeuse P. Halothane, an effective infrequently used drug, in the treatment of pediatric status asthmaticus: a case report. J Asthma 2005; 42: 649-651 (Pubitemid 41609531)
36. Revich LR, Grinspon SG, Paredes C, Moreno E, Gene R, Jorge MA. Respiratory effects of halothane in a patient with refractory status asthmaticus. Pulm Pharmacol Ther 2001; 14: 455-460 (Pubitemid 34081697)
37. Rosseel P, Lauwers LF, Baute L. Halothane treatment in life-threatening asthma. Intens Care Med 1985; 11: 241-246
38. Saulnier FF, Durocher AV, Deturck RA, Lefebvre MC, Wattel FE. Respiratory and hemodynamic effects of halothane in status asthmaticus. Intens Care Med 1990; 16: 104-107 (Pubitemid 20277722)
39. Schwartz SH. Treatment of status asthmaticus with halothane. JAMA 1984; 251: 2688-2689
40. Padkin AJ, Baigel G, Morgan GA. Halothane treatment of severe asthma to avoid mechanical ventilation. Anaesthesia 1997; 52: 994-997 (Pubitemid 27455516)
41. Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 1986; 14: 832-833 (Pubitemid 16003116)
42. Johnston RG, Noseworthy TW, Friesen EG, Yule HA, Shustack A. Isoflurane therapy for status asthmaticus in children and adults. Chest 1990; 97: 698-701. (Pubitemid 20095594)
43. Maltais F, Sovilj M, Goldberg P, Gottfried SB. Respiratory mechanics in status asthmaticus. Effects of inhalational anesthesia. Chest 1994; 106: 1401-1406
44. Miyagi T, Gushima Y, Matsumoto T, Okamoto K, Miike T. Prolonged isoflurane anesthesia in a case of catastrophic asthma. Acta Paediatr Jpn 1997; 39: 375-378 (Pubitemid 27276384)
45. Revell S, Greenhalgh D, Absalom SR, Soni N. Isoflurane in the treatment of asthma. Anaesthesia 1988; 43: 477-479
46. Rice M, Hatherill M, Murdoch IA. Rapid response to isoflurane in refractory status asthmaticus. Arch Dis Child 1998; 78: 395-396 (Pubitemid 28180571)
47. Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intens Care Med 2006; 32: 927-933 (Pubitemid 43781379)
48. Wheeler DS, Clapp CR, Ponaman ML, Bsn HM, Poss WB. Isoflurane therapy for status asthmaticus in children: A case series and protocol. Pediatr Crit Care Med 2000; 1: 55-59
49. Hirshman CA, Edelstein G, Peetz S, Wayne R, Downes H. Mechanism of action of inhalational anesthesia on airways. Anesthesiology 1982; 56: 107-111 (Pubitemid 12164874)
50. Habre W, Wildhaber JH, Sly PD. Prevention of methacholine-induced changes in respiratory mechanics in piglets: a comparison of sevoflurane and halothane. Anesthesiology 1997; 87: 585-590 (Pubitemid 27433008)
51. Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981; 54: 100-106
52. Watanabe K, Mizutani T, Yamashita S, Tatekawa Y, Jinbo T, Tanaka M. Prolonged sevoflurane inhalation therapy for status asthmaticus in an infant. Paediatr Anaesth 2008; 18: 543-545 (Pubitemid 351600193)
53. Mori N, Nagata H, Ohta S, Suzuki M. Prolonged sevoflurane inhalation was not nephrotoxic in two patients with refractory status asthmaticus. Anesth Analg 1996; 83: 189-191 (Pubitemid 26225399)
54. Que JC, Lusaya VO. Sevoflurane induction for emergency cesarean section in a parturient in status asthmaticus. Anesthesiology 1999; 90: 1475-1476
55. Schultz TE. Sevoflurane administration in status asthmaticus: a case report. AANA J 2005; 73: 35-36 (Pubitemid 40209304)
56. Mazzeo AT, Spada A, Pratico C, Lucanto T, Santamaria LB. Hypercapnia: what is the limit in paediatric patients? A case of near-fatal asthma successfully treated by multipharmacological approach. Paediatr Anaesth 2004; 14: 596-603. (Pubitemid 38869929)
57. Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol 2005; 19: 523-538. (Pubitemid 40753816)
58. Migliari M, Bellani G, Rona R, Isgro S, Vergnano B, Mauri T, et al. Short-term evaluation of sedation with sevoflurane administered by the anesthetic conserving device in critically ill patients. Intens Care Med 2009; DOI 10.1007/s00134-009-1414-7.
59. Sackey PV, Martling CR, Radell PJ. Three cases of PICU sedation with isoflurane delivered by the 'AnaConDa'. Paediatr Anaesth 2005; 15: 879-885
60. Thomson H, Harper NJ, Parkes A. Use of the AnaConDa anaesthetic delivery system to treat life-threatening asthma. Anaesthesia 2007; 62: 295-296 (Pubitemid 46680663)